Want to see GENB full AI Analyst Report?
Generate Biomedicines, Inc. (GENB) Ownership Overview
52.07% Insiders
<0.01% Mutual Funds
0.01% Other Institutional Investors
3.02% ETFs
44.89% Public Companies and
Individual Investors
The ownership structure of Generate Biomedicines, Inc. (GENB) stock is a mix of institutional, retail, and individual investors. Approximately 3.04% of the company’s stock is owned by Institutional Investors, 52.07% is owned by Insiders, and 44.89% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 06, 2026 | xxxxxxxxxxxxx | $240000 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $75000000 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $32000 | |
Mar 02, 2026 | xxxxxxxxxxxxx | $4800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2026 | xxxxxxxxxxxxx | $6230100 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $17795025 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $783413963 | |
Mar 31, 2026 | xxxxxxxxxxxxx | $21527625 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 62,673,117 | Institution | 48.89% | 849,847,467 | |
| 62,673,117 | Insider | 48.89% | 849,847,467 | |
| 2,889,154 | Insider | 2.25% | 39,176,928 | |
| 1,722,210 | Institution | 1.34% | 23,353,168 | |
| 1,423,602 | Institution | 1.11% | 19,304,043 | |
| 1,315,734 | Institution | 1.03% | 17,841,353 | |
| 1,280,640 | Institution | 1.00% | 17,365,478 | |
| 1,184,989 | Insider | 0.92% | 16,068,451 | |
| 782,033 | Institution | 0.61% | 10,604,367 | |
| 498,408 | Institution | 0.39% | 6,758,412 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,500 | Institution | <0.01% | 115,260 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,247,089 | Institution | 0.97% | 16,910,527 | |
| 816,876 | Institution | 0.64% | 13,780,698 | |
| 624,270 | Institution | 0.49% | 8,465,101 | |
| 296,479 | Institution | 0.23% | 5,001,601 | |
| 156,648 | Institution | 0.12% | 2,124,147 | |
| 140,478 | Institution | 0.11% | 2,369,864 | |
| 139,288 | Institution | 0.11% | 1,888,745 | |
| 119,988 | Institution | 0.09% | 1,639,036 | |
| 68,645 | Institution | 0.05% | 930,826 | |
| 51,120 | Institution | 0.04% | 698,299 |
FAQ
Who Owns Generate Biomedicines, Inc. (GENB)?
According to the latest TipRanks data, approximately 0.01% of the company's stock is held by institutional investors, 52.07% is held by insiders, and 44.89% is held by retail investors.
What percentage of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.01% of Generate Biomedicines, Inc. (GENB) stock is held by institutional investors.
What percentage of Generate Biomedicines, Inc. (GENB) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.89% of Generate Biomedicines, Inc. (GENB) stock is held by retail investors.
Who owns the most shares of Generate Biomedicines, Inc. (GENB)?
Noubar Afeyan owns the most shares of Generate Biomedicines, Inc. (GENB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.